Fellow Login

Fellowbook News

College Of Fellows

Donation After Circulatory Death Kidney Transplant Outcomes Not Affected by Wait Time

Extending wait time criteria from 1 to 3 hours after withdrawal of life-sustaining treatment for kidney donation after circulatory death (DCD) does not compromise kidney transplant outcomes and may help ease the organ shortage, investigators report.

The UK stipulates a 3-hour minimum observation time after withdrawal of life support before potential donors are no longer considered eligible to donate. In the US, typical practice is to wait no longer than 1-2 hours. Expanding the window of time might substantially increase the number of viable kidneys available for transplantation in the US and internationally, according to Samuel J. Tingle, MBBS, of Newcastle University in the UK, and colleagues… Continue reading.

More News from Matthew Bacchetta, MD

Matthew Bacchetta, MD
New method enables recovery of hearts from deceased organ donors after circulatory death
Vanderbilt University Medical Center researchers have developed a groundbreaking new method for the recovery of hearts from deceased organ donors after circulatory death (DCD). The method (rapid recovery with extended ultra-oxygenated preservation [REUP]),...
Matthew Bacchetta, MD
Process rehabilitates donor livers for transplantation
Not enough suitable donor livers are available, meaning that patients nationwide die every day while waiting on the transplant list. But a multidisciplinary team from Vanderbilt University Medical Center recently published research that shows promise...
Matthew Bacchetta, MD
Bacchetta named chair of Thoracic Surgery
Matthew Bacchetta, MD, MBA, MA, associate professor of Thoracic Surgery, has assumed his new role as chair of Vanderbilt University Medical Center’s Department of Thoracic Surgery, as of July 2021. Bacchetta, an internationally renowned National Institutes...
Matthew Bacchetta, MD
Vanderbilt performs world’s first heart, lung transplant of COVID-19 patient
Vanderbilt University Medical Center says it performed the world’s first dual heart-lung transplant of a COVID-19 patient in September. Vanderbilt says the patient, described as a young man, had cardiomyopathy – a disease of the heart tissue that can...
Nature Medicine Matthew Bacchetta, MD
Xenogeneic cross-circulation for extracorporeal recovery of injured human lungs
Medical, surgical and technological advancements in organ transplantation continue to expand life-saving treatment options for patients with end-stage lung disease, but transplantation remains limited by the low availability of donor organs. As chronic...
Fellow Login